Epidemiology journals by time to acceptance (2025)
70 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Hepatology | 5 (1–93) | 407 | 23 | ≈$2,900 | Hybrid | 0.0 |
| Medical Mycology Case Reports | 55 (33–84) | 65 | 3 | $650 | Open access (DOAJ) | 0.0 |
| Infectious Diseases and Therapy | 58 (39–84) | 174 | 21 | $7,675 | Open access (DOAJ) | 0.0 |
| European Burn Journal | 59 (50–76) | 62 | 6 | ≈$1,039 | Open access (DOAJ) | — |
| The Lancet. Gastroenterology & hepatology | 63 (14–96) | 114 | 91 | ≈$7,280 | — | 1.77 |
| Pediatric Cardiology | 64 (44–99) | 347 | 15 | ≈$3,790 | — | 0.0 |
| Infection and Chemotherapy | 64 (40–86) | 60 | — | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Clinical and Molecular Hepatology | 67 (9–106) | 119 | 4 | ≈$1,472 | Open access (DOAJ) | 0.0 |
| European Stroke Journal | 67 (51–79) | 87 | — | ≈$4,400 | — | 10.68 |
| Hepatology Communications | 71 (43–121) | 228 | 76 | $2,700 | Open access (DOAJ) | 0.83 |
| Infection | 71 (46–99) | 223 | 14 | ≈$4,790 | Hybrid | 0.0 |
| CJC Pediatric and Congenital Heart Disease | 73 (45–108) | 53 | 8 | $2,100 | Open access (DOAJ) | — |
| Transplant Infectious Disease | 76 (56–109) | 95 | 18 | ≈$3,920 | — | 0.0 |
| Hepatology Research | 77 (52–118) | 150 | 12 | ≈$3,400 | Hybrid | 0.0 |
| European Journal of Clinical Microbiology & Infectious Diseases | 80 (46–119) | 346 | 14 | ≈$2,890 | Hybrid | 1.69 |
| Antiviral Research | 80 (58–128) | 167 | 1 | ≈$4,160 | Hybrid | 0.0 |
| Hepatology International | 81 (65–109) | 99 | 33 | ≈$3,090 | — | 0.0 |
| IDCases | 82 (53–134) | 327 | 1 | $1,750 | Open access (DOAJ) | 0.72 |
| Enfermedades infecciosas y microbiologia clinica (English ed ) | 82 (53–112) | 112 | 102 | ≈$2,280 | — | 0.0 |
| Clinical Infectious Diseases | 83 (65–111) | 179 | — | ≈$4,763 | Hybrid | 0.58 |
| Infectious Agents and Cancer | 83 (64–113) | 89 | 22 | $3,290 | Open access (DOAJ) | 0.0 |
| Virology Journal | 87 (57–128) | 417 | 20 | $3,390 | Open access (DOAJ) | 0.0 |
| Translational Pediatrics | 87 (69–111) | 346 | 43 | — | Open access | 0.82 |
| Journal of Infection and Chemotherapy | 87 (64–121) | 272 | 2 | ≈$2,650 | — | 1.46 |
| Journal of Clinical and Translational Hepatology | 87 (64–116) | 94 | 21 | — | Open access | 0.0 |
| Journal of Clinical Virology | 87 (63–123) | 89 | 2 | ≈$4,210 | Hybrid | 1.78 |
| Drug and Alcohol Dependence Reports | 87 (61–123) | 84 | 2 | $2,230 | Open access (DOAJ) | 0.0 |
| Reviews in Medical Virology | 88 (45–148) | 71 | — | ≈$4,880 | — | 0.0 |
| Journal of Stroke and Cerebrovascular Diseases | 90 (60–142) | 292 | 1 | $2,170 | Open access (DOAJ) | 0.45 |
| ASM Case Reports | 93 (71–132) | 94 | 27 | — | — | — |
| Mycoses | 94 (63–127) | 123 | — | ≈$4,780 | — | 0.0 |
| Revista do Instituto de Medicina Tropical de São Paulo | 96 (70–137) | 83 | 56 | $500 | Open access (DOAJ) | 0.0 |
| Annals of Hepatology | 98 (70–140) | 102 | 36 | $1,500 | Open access (DOAJ) | 0.0 |
| World Journal of Hepatology | 99 (80–129) | 248 | — | — | Open access | 0.0 |
| Journal of Infection | 99 (71–134) | 185 | 5 | $4,030 | Open access (DOAJ) | 0.0 |
| Mycopathologia | 101 (70–139) | 117 | 23 | ≈$4,190 | — | 0.0 |
| Open Forum Infectious Diseases | 102 (70–139) | 708 | 5 | $3,859 | Open access (DOAJ) | 0.28 |
| Clinical Microbiology and Infection | 103 (66–138) | 280 | 7 | ≈$3,780 | Hybrid | 0.0 |
| Journal of Clinical and Experimental Hepatology | 105 (75–152) | 134 | 7 | ≈$3,150 | — | 1.3 |
| The Journal of Infectious Diseases | 109 (78–145) | 495 | — | ≈$4,763 | Hybrid | 0.37 |
| Vaccine | 110 (71–180) | 1,158 | 9 | ≈$3,620 | Hybrid | 0.0 |
| Medical Mycology | 111 (75–152) | 127 | — | ≈$4,889 | Hybrid | 0.0 |
| Annals of Pediatric Cardiology | 111 (70–155) | 112 | 91 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Tuberculosis | 112 (84–140) | 67 | 1 | ≈$2,690 | — | 0.0 |
| Journal of Optometry | 112 (85–148) | 56 | 34 | $1,850 | Open access (DOAJ) | — |
| Journal of Addiction Medicine | 114 (82–159) | 186 | 32 | — | — | 0.0 |
| Journal of Burn Care & Research | 120 (79–168) | 211 | — | ≈$3,698 | — | 0.0 |
| Alcohol and Alcoholism | 122 (78–200) | 88 | — | ≈$4,286 | — | 0.0 |
| International Journal of Drug Policy | 123 (85–162) | 308 | 11 | ≈$4,350 | — | 0.0 |
| Journal of Medical Virology | 125 (89–167) | 563 | — | ≈$4,730 | Hybrid | 0.92 |
| Journal of Viral Hepatitis | 125 (83–181) | 123 | — | ≈$4,610 | — | 1.64 |
| American Journal on Addictions | 134 (96–164) | 56 | 14 | ≈$3,920 | — | 0.0 |
| Journal of the Pediatric Infectious Diseases Society | 135 (85–172) | 102 | — | ≈$4,752 | — | 0.0 |
| Influenza and Other Respiratory Viruses | 136 (97–194) | 125 | — | $4,840 | Open access (DOAJ) | 0.0 |
| Liver International | 138 (96–205) | 297 | — | ≈$4,780 | Hybrid | 0.0 |
| Drug and Alcohol Dependence | 144 (108–189) | 343 | 8 | ≈$4,380 | Hybrid | 0.0 |
| International Breastfeeding Journal | 154 (117–206) | 108 | 19 | $3,190 | Open access (DOAJ) | 0.0 |
| Addiction | 164 (99–220) | 279 | 40 | ≈$4,600 | — | 0.85 |
| Therapeutic Advances in Infectious Disease | 164 (120–219) | 94 | 35 | $2,800 | Open access (DOAJ) | 0.0 |
| Burns | 165 (116–241) | 249 | 2 | ≈$3,190 | Hybrid | 0.0 |
| Journal of Hepatology | 170 (68–227) | 183 | 18 | ≈$5,500 | Hybrid | 0.93 |
| Canadian Journal of Infectious Diseases and Medical Microbiology | 181 (140–260) | 84 | 22 | $2,380 | Open access (DOAJ) | 0.0 |
| Harm Reduction Journal | 188 (128–251) | 235 | 28 | $3,390 | Open access (DOAJ) | 0.0 |
| Journal of Substance Use and Addiction Treatment | 190 (147–241) | 152 | 5 | ≈$3,440 | — | 0.0 |
| Journal of Tropical Medicine | 193 (140–247) | 72 | 23 | $1,790 | Open access (DOAJ) | 0.0 |
| Drug and Alcohol Review | 201 (136–259) | 179 | 20 | ≈$4,430 | — | 0.0 |
| Case Reports in Infectious Diseases | 206 (144–284) | 123 | 20 | $870 | Open access (DOAJ) | 0.0 |
| Addiction Science & Clinical Practice | 210 (159–280) | 101 | 18 | $2,890 | Open access (DOAJ) | 0.0 |
| Substance Abuse Treatment Prevention and Policy | 210 (144–277) | 65 | 22 | $3,190 | Open access (DOAJ) | 0.0 |
| OTA International The Open Access Journal of Orthopaedic Trauma | 233 (77–322) | 80 | 55 | $1,900 | Open access (DOAJ) | 0.0 |
Journals are listed where at least 25% of their articles' topics fall in Epidemiology (OpenAlex).
Latest available year: 2024
5 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Clinical Liver Disease | 46 (31–74) | 105 | 78 | — | — | 0.0 |
| International Journal of Cardiology Congenital Heart Disease | 55 (20–102) | 63 | 2 | $2,260 | Open access (DOAJ) | 0.0 |
| Journal of Stroke | 95 (66–132) | 56 | 101 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Caspian journal of internal medicine | 139 (99–210) | 79 | 343 | $1,200 | Open access (DOAJ) | 0.0 |
| Journal de Mycologie Médicale | 207 (146–285) | 52 | 1 | ≈$3,250 | — | 0.0 |
Latest available year: 2023
3 journals without enough usable 2025 data. Their 2023 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Clinical and Experimental Hepatology | 55 (37–82) | 55 | 69 | ≈$1,130 | Open access (DOAJ) | 0.0 |
| Problems of Social Hygiene Public Health and History of Medicine | 73 (62–111) | 220 | — | — | — | 0.0 |
| Journal of preventive medicine and hygiene | 108 (30–179) | 54 | 42 | — | Open access | 0.0 |
Latest available year: 2022
2 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Substance Abuse Research and Treatment | 103 (77–142) | 58 | 35 | $2,650 | Open access (DOAJ) | — |
| Journal of Substance Abuse Treatment | 184 (141–234) | 109 | 7 | ≈$3,340 | — | 0.0 |
Latest available year: 2021
2 journals without enough usable 2025 data. Their 2021 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Journal of Clinical Microbiology | 87 (57–123) | 59 | 64 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Revista chilena de infectología | 148 (98–220) | 87 | — | — | Open access | 0.0 |
Latest available year: 2020
2 journals without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| European Addiction Research | 175 (109–237) | 59 | 64 | — | — | — |
| Nordic Studies on Alcohol and Drugs | 184 (147–254) | 51 | 69 | No fee (DOAJ) | Open access (DOAJ) | — |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Epidemiology journals accepted papers fastest in 2025?
Among 70 Epidemiology journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 5 days (Hepatology). The middle journal's median was 101 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.